$4.88 0.06 (+1.24%)
2/13/2012 9:55 AM

Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Featured Broker Partners


Advertisement